Mitoregulin Controls β-Oxidation in Human and Mouse Adipocytes

Area of Science:

• Metabolic research
• Molecular biology
• Genetics

Background:

• A long non-coding RNA (lncRNA) in mouse adipocytes, homologous to human LINC00116, was previously found to regulate adipogenesis.
• This lncRNA contains a conserved coding region with potential protein-coding capacity.

Purpose of the Study:

• To investigate the protein expression and function of the peptide encoded by human LINC00116, identified as mitoregulin (MTLN).
• To determine MTLN's role in adipocyte metabolism, specifically triglyceride clearance, lipolysis, and mitochondrial fatty acid oxidation.

Main Methods:

• Analysis of human protein expression from LINC00116.
• Functional studies in human stem cell-derived adipocytes and isolated murine adipocytes.
• Investigation of systemic lipid phenotypes in knockout mice.
• Biochemical assays to determine MTLN's interaction with mitochondrial proteins.

Main Results:

• Human protein expression of a peptide within LINC00116 (MTLN) was confirmed.
• MTLN modulates triglyceride clearance in human adipocytes by regulating lipolysis and mitochondrial beta-oxidation.
• MTLN directly interacts with the beta subunit of the mitochondrial trifunctional protein, crucial for fatty acid oxidation.
• Knockout mice exhibited systemic lipid phenotypes, and both murine and human adipocytes showed autonomous MTLN phenotypes.

Conclusions:

• MTLN plays a significant regulatory role in adipocyte metabolism.
• MTLN's function in promoting white adipocyte triglyceride clearance presents a potential therapeutic avenue for obesity.
• Further research is warranted to explore MTLN's therapeutic potential, considering associated caveats.